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AN ABSTRACT OF THE THESIS OF Debra Ann Weyant tor the Master ot 
Science in Biology presented May 18, 1979 •. 
Ti~le: Androgfn-Induced Immunosuppression. 
',.,1 
APPROVED BY MU(B~ OF.THE T¥F.SIS _COMMITTEE: 
David T. Clark, Chairman 
It is wel females are more immunocompetent 
than males as evidenced by higher humoral antibody titers, iowered· 
susceptibility to infection, ~d more efficient graft rejection. 
Furthermore, females also exhibit a much-higher inc~dence ot ~uto-
immune disease. These observations have led investigato~e to believe 
that the male hormonal environment may play a ke1 role 1~ the r•gu- . 
lation ot illlJllune response. For this reason, this study is conc~rned 
With the exp~eseion ot autoimmunity and ot immune f~netion in.the mouse •. 
 
I' 
!. 
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This study included the New Zealand Black (NZB) mouse strain, as 
an animal model for human SLE, as well as normal DBA/2 and Balb/c 
strains. Animals were administered testosterone via subcutaneous im-
plants in silastic tubing or by injection. Mice used were intact 
females, intact males and castrated males. Animals were otherwise un-
treated or bad been exposed to a aublethal dose (400-550'rads) of 
irradiation. Target organ weight changes, immune cap~city and peri-
pheral blood picture changes were measured. 
In all experiments, marked changes in seminal vesicle, kidney 
and thymus weights were observed following castration or testosterone 
treatment. However, numbers of spleen plaque-forming cells following 
SRBC immunization were not significantly changed in normal or auto-
immune strain mice not receiving irradiation. 
In order to amplify the sensitivity of the responding system, we 
then elected to study testosterone immunosuppression in a regenerating 
hemopoietic system which was recovering from the ablative effects of 
sublethal irradiation. 
It w~s observed, using ~rradiated mice, that orchidectomy re-
sulted in striking immunoenhancement, where as testosterone treatment 
produced suppression of the antibody response to S~BC immunization. 
A possible mechanism for the testosterone effect consisting of a 
preferential differentiation of the regenerating stem cell population 
~long the myeloid pathway was explored. Differential white blood cell 
counts indicated that testosterone administration can produce a rever-
sal ot the granulocyte:lymphocyte ratio resulting in a marked granulo-
cytosis ~ith acco~panying lymphopenia. Interestingly, in one experiment 
where testosterone had been observed to induce this reversal of the 
granulocyte:lymphocyte ratio at eight weeks following irradiation, by 
12 week~ the blood picture had returned to normal. However, marked 
immunosuppression was still evldent in these animals. 
3 
These data have suggested that the immunosuppression pro~uced by 
testosterone may be the result of a preferential differentiat~on of.the 
regenerating stem cell population along the myeloid pathway, with a 
concurrent suppression of lymphocyte production. Furthermore, evidence 
suggests that there may be a selective sensitivity of one immunocyte 
subpopulation to testosterone modulation of differentiation. 
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CHAPTER I 
INTRODUCTION 
Hormonal stimulation and modulation ot lymphatic tissue has been 
 recognized tar some time as a normal mechaniam·in dev•lop•ent (1). · 
Growth hormone and thyroxine are important hormones in the maturation 
ot the immune system and ~reatly affect the immunological capability ot · 
the adult (1). The effects of the steroid hormones, and, in particular, 
the sex hormones,. are clearl~ evident in the marked differences reported 
between male and female immunological responses. F~males ~e more immuno-
competent than males as evidenced by higher humoral ant~body p~oduQtion 
(2,3), lowered susceptibility to inf~ction (4,5), and.more efficient 
graft rejection (6). In addition, the incidence ot autoimmune disease, 
tor example,. systemic lupus erythematosua (SLE), has long been· noted 
to be hig~er in females than males during the reproductive years (7,8,9); 
the temale:male ratio ot SLE in humans being approximately 9:1 (10), 
These observations have lad investigators to believe that the male 
hormonal environment may play a key role in the regulation of immune 
response. For this reason, this study is concerned with evaluating· 
the possible role and mechanism ot androgen modulation ot the expression 
ot autoimmunity and ot immune function in the mouse. 
The animal model for human systemic lupus erythematosus u~ed.in 
this study is the New Zealand Black (NZB) mouse strain. The NZB'de~ 
velops an autoimmune disease characterized by the production of anti-
2 
DNA autoantibodies with a resultant glomerular nephritis of the kidneys, 
and a .general immune function imbalance, i.e., hyperactive humoral and 
cellular immune responses when young; impaired function when old (11). 
In addition, the sex differences noted in lupus are present in NZB mice 
where females manifest an earlier ~nset ot disease and usually die much 
earlier than the males (12). Therefore, the NZB provides a valuable 
model tor experimentation in this field ot research. 
In order to modify the hormonal environment in several strains of 
normal and autoimmune mice, intact and castrated males as· well ~s intact 
females were administered testosterone either by injection or by subcu-
taneous implantation of testosterone-contained silaatic tubing. 
CHAPTER II 
REVIEW OF THE LITERATURE 
STEROID HORMONES AND LYMPHOID TISSUES 
Early work had showa that the exogenous administration of an-
drosterone, 5-androstenediol, testosterone and testosterone propio-
nate resulted in thymic atrophy in intact or c~strated animals (13,14, 
15). Androsterone and testosterone propionate were found to be the . 
most effective (16). Eetrogenic compounds also produce thymic ~nvolu­
tion in puppies (1?) and rata-(18,19) as does progesterone (20), but 
only in large aaounts. Money !.1 !! (18} tested the activity ot various 
ste~oids, 1.e., ACTH, cortisone, 11-dehydrocorticosterone, 17«i-hydroxy-
11,21-acetoxy-desoxycorticosterone, l?p-hydroxyprogesterone, de~o~~ 
corticosterone, de,P.Ydrocortisone, pregnenolone, te·~toaterone, p:rog~s~ 
terone, and various estrogens. All were found to produce thymic in-
volution. ACTH, cortisone and 11-dehydrocorticosterone were.shown to. 
effect lymph nodes as well. 
Gonadotrophins will also produce acute involution of the thymus, 
but only in intact animalS. Castration blocked this thymolytic effect 
in the rat (21), suggesting that the ~onadotrophic-induced involution 
was mediated through the release ot the sex hormones from stimulated 
gonadal organs. In addition, the action ot the sex ~or~ones on t~e 
thymus was not reversed by adrenalectomy in rats. However, those 
compounds related chemically to the sex hormones, but not hormonally 
active, had no thymolytic activity in adrenalectomized rats (19). 
These data indicate a direct link between hormonally acitve sex hor-
mones and _thymic integrity. 
The mechanism ot action of adrenocortical hormones on lymphatic 
tiasues ot mice, rate and rabbits was also investigated ( 22,23_). It 
was reported that ACTH or adrenocortical e~racts produced a marke~ 
decrease in lymphocyte numbers and a cessation ot mitoa1a·1n small and 
medium-sized lymphocytes. In addition, severe degenerative changes in 
the cells were noted. Lymphocytolysis could also be produced in vitro 
(24,25,2Q). However, lymphocytolysis could not entirely explain pro-
lon~•d or sustained atrophy. Bak~r ~ !!_ (27) reported the absence of 
many mitotic figures on prolonged ACTH treatment and c~ncluded that 
suppression of lymphocytopoiesis was the more likely mechanism of pro-
longed thymic involution. Dougherty (28) confirmed these conclusions 
with hie~ological observations. Conversely, gonadectomy. ot either the 
male or ~emale mouse produced thymic enlargement· (3,29). It was 
suggested that gonadal hormones exert a constant modera~ing influence 
on the growth and maintenance of lymphatic organs. 
Hormonal effects on blood or peripheral lymphocytes were also 
investigated. Daily injections ot ACTH in mice (30); rats and rabbits 
(31) produced a significant decrease in the numbers of circulating 
lymphocytes. The~e early reports showed no significant changes in 
blood lymphocyte. levels with either gonadectomy or administration ot 
exogenous testosterone (32). 
4 
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In the chicken, treatment with androgens induced bursal involution 
(33). The bursa of Fabricius is a major immunological organ in the 
chicken where it serves as the site of B-cell maturation. Also, it was 
tound that 19-nortestoaterone could also prevent the development Qf 
the bursa ot Fabricius in chick embryos (34). Chicks treated with 
testosterone as embryos are unable to produce a detectable antibody 
response (35). Thymus development was also shown to be suppressed in 
about 40 per cent ot these treated embryos (36). 
More recently, Eidinger and Garrett (3), looking at the effects of 
castration on lymphoid tissue, substantiated the earlier reports ot 
thymic enlargement. They also reported an increase in the spleen 
weight of castrated male mice. In comparing females with intact and 
castrated ma.lea, the intact males exhibited the S111alleat spleens and 
thyaueea, the female organs were significantly larger, but the largest 
organs were tound in the castrated males. They were also able to show 
that it was an increase in the number ot cortisone-sensitive or immature 
thymic lymphocytes that resulted in thymic and splenic enlargement. 
This observed thymic hypertrophy with castration c·ould be reversed 
by the administration of replacement dose ot testosterone, and hormone 
supplements to normal mice produced an accelerate~ rate of ~hymic in-
volution. Similar hypertrophy ot the lymph nodes was also note~ with 
orchidectomy, but not in combined thymectomy and orchidectomy~ Histo-
logical examination of the enlarged nodes showed an increase in thick-
ness of the paracortical or T-dependent region, suggesting the import-
ance of the thymus in castrat~on-induced nodal enlargement (29). 
In studies in which mice were given a single injection of testo-
sterone immediately following irradiation and marrow reconstitution, 
6 
severe depletion of the thymus-independent (B-cell) regions ot the spleen, · 
lymph nodes and Peyer•s patches were noted. Also the $ize of the lymph 
follicles in these organs were decreased with testosterone treat~ent 
as ~ompared to irradiated controls. Mature plasma cells we~e unaff•ct-
··d~ Myelopoiesis and particularly erythropoiesis was stimulated in 
these testosterone-treated mice (37). 
INFLUENCE OF TESTOSTERONE ON ANTIBODY PRODUCTION 
As previously mentioned, males tend to be less responsive 
immunologically than females. Females respond to antigenic stimulation 
with higher humoral antibody production {2,3), and are leas susceptible 
to infection (4,5). Investigations have indicated that testosterone 
plays a primary role in regulating antibody response. 
In experiments where castration of the males had been performed, 
Eidinger and Garrett (3) found that the primary immune response to 
polyvinylpyrrolidone (PVP), a T-independent antigen, was significantly 
higher than in intact males and even exceeded that of the females. 
When a T-dependent antigen was used, a signitiean~ly large difference 
was apparent in the early 19 S phase ot the response to horse erythro-
cytes. The gonadectomized males exhibited early antibody titers com-
. parable to the female which far exceeded that ot intact males. There 
was no difference between gonadectomized and intact males by 20 days 
post immunization. Secondary antibody responses to erythrocytes were 
similar for castrated males and normal females, but both responses 
7 
exceeded those ot intact males. Thus, when T-dependent antigens were 
used tor immunization, castration appeared to convert the male response 
to that ot the female. However, castration, induced a responsiveness to 
PyP, the T-independent antigen, which exceeded even that ot the female. 
When thymectomy accomp,anied castration, the enhanced antibody response 
to PVP was abolished auggeati~g a role ot the thymus in this, phenomenon. 
It was suggested that the enhancement could be mediated thrqugh a tbymio 
enhancing factor or hormone. 
However, in a similar experiment looking at the late phase of the 
oxazolone reaction and response to pnewzaococcal polysaccharide (SIII) 
immunization, both ~-independent responses, no significant differences 
between the orchidectomized and intact male mice were detected. They 
did, however, show a significant increase in antibody response to sheep 
erythrocytes with castration (29). 
While castration has an enhancing effect on antibody production, 
Fujii .!!. !!. (3?) showed that the administration ot a single intraperi-
toneal injection ot 10 milligrams of testosterone could significantly 
suppress the plaque-forming cell response of normal intact female C3H/He 
mice to sheep erythrocyte immunization tor up to,30 days., ~st~logically, 
no differences in cellularity of lymphoid tiaaues,were observed between 
treated and untreated groups. Interestingly, this same antibody re~ 
sponse could be suppressed for as long as 60 days by a single testoater-
· one injection immediately following lethal irradiation and bone marrow 
cell reconstitution. Histological examination of lymp~oid tissu~s at 
30 days re·vealed severe depletion of thymic-independent, B-cell, areas 
of spleen, lymph nodes and Peyer•s patches in the testosterone-treated 
8 
group, but these areas had fully recovered by 60 days. By 90 days, an-
tibody suppression was also no longer evident. 
In autoimmune NZB mice, th~ production of autoantibodies, as well 
as antibodies to foreign antigens, is much more pronounced in the female 
(11,lZ). A naturally occurring thymocytotoxic autoantibody (NTA) has 
also been found to be abnormally high in young NZB•s (38). Raveche et 
!Y:_ (39) determined that (NZB X DBA/2)F1 females showed a significantly 
higher incidence of a positive test for this antibody as compared t9 the 
hybrid males and a higher titer in NTA-positive females than in NTA-
positive males. Castration of the females had n~ effect on either 
parameter ot NTA measurement, but castration of the male increased the 
incidence and titer of antibody to equal those seen in the female. 
Failure of the NZB-mothered F1 males to produce NTA did not substantiate 
an x-linked immune response hypothesis. These data lend further support 
to the important role of male sex hormonea in the expression of auto-
immunity. 
Roubinian and coworkers (40) asked the question: Can survivals 
in murine lupus be improved with androgenic hormones? They found that 
prepuberal castration of the male NZB accelerated the rate ot death from 
.disease in 60 per cent of these mice. Castration of the female had no 
effect on survival. However, treatment of NZB females with natoxidine, 
an anti-estrogenic agent, led to a decrease in anti-DNA antibodies a.nd 
an increase in survival (41). When the administration of androgen 
followed castration Of the female, a dramatic decrease in mortality 
was observed to 14 from 94 per cent tor the intact female. Furthermore, 
the titer ot anti-DNA antibodies was significantly lees in androgen-
9 
compared to estrogen-treated females. Male castration accelerated the 
age of appearance of anti-DNA autoantibodies in the male NZB and facili-
tated an.earlier switch from IgM to IgG immunoglobulin. The earli~r 
appea»ance or 7S anti-DNA antibody has been correlated with the mo~e 
eevere disease of the female (40). While sham-operated males developed 
?S IgG ~ti-DNA antibodies at seven months ot age, thee~ ~tibodies 
made a much earlier, tour-month, appearance in the ca•trated male, 
which was the age of their development in the normal NZB female. 
Interestingly, results similar to the effects ot orchidectomy could be 
achieved with neonatal thymectomy. Neonatal thymectomy was found.to· 
produce initial increases in anti-DNA and poly-A antibody formation and 
prevent the later eWitch to 78 antibodies observed in the NZB males. 
This led these investigators to propose that the thymus is the target 
tor, or mediates, the androgen effect (42). 
Other parameters ot murine systemic lupus were also alleviated 
by androgen treatment ot castrated females. Proteinuria was signifi-
cantly decreased and the degree ot lymphocytic infiltration and 
glomerular inflammation of the kidneys was lessened. other investiga-
tors have obtained similar results (43). 
With the protective effects of androgen in murine ~upus in mind, 
Stahl and Decker (44) looked at the andro~enic status of 12 men w~th 
human systemic lupus. They could find no deficiency in serum levels of 
testosterone, luteinizing hormone, or follicle-stimulating hormone. 
They concluded that gonadal function in these men was not.a primary 
factor in their disease. 
10 
EFFECTS OF TESTOSTERONE ON STEM CELL DIFFERENTIATION 
Currently, work by Abramson !!. !!, (45) supports the monophyletic 
theory that tho pluripot1ntial hemopoietie atem cell is the precursor 
ot all myeloid and lymphoid components ot blood and lymph. From.this 
cell is derived the restricted or committed pr~cursor of these elem~nta. 
A single precursor cell is thought to be the parent ot the erythrocyte,. 
granulocyte and megakaryocyte populations. A separate, precursor c·81l. 
arising trom the stem cell was shown to be committed to the T-lympho-
cyte .pathway ot differentiation, and B-cells, the antibody producers, 
apparently arise directly from the stem cell without a committe~ progeni-
tor as an intermediate. Most importantly, they provide evidence which 
suggests that there ie not a separate lymphocytic stem· cell, or pro-
genitor cell,giving rise to both T and B cells. This differentiation 
scheme is presen tad in Figure '1 • In the mouse, these pluripotential · 
stem cells are located in the hemopoietic ti~sue Of the embryonic yolk 
sac, tetal liver, spleen and bone marrow.(46). 
Factors influencing the pathways of differentiation of this 
pluripotential cell.could play an important role in the establishment 
ot popul~tions of these various cells. One such factor to have a known 
modulating influence is testosterone. Its potent erythrogenic capa-
bilities have been known tor many years. Testosterone has been used 
in treatment ot patients with aplastic anemia (47), multiple myeloma 
(48), pure red cell aplasia (49), chronic lymphocytic leukemia (50), 
namely., those diseases in which anemia was a major symptom. The 
mechanism of this erythropoietic action has been proposed to be, at 
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least in part, through stimulation ot erythropoietin production by the 
kidney (~1). Elevated levels ot serum erythropoietin following test-
O•terone have been reported (52). Interestingly, Jepson (53) has 
12 
postulated that testosterone may first influence bone marrow s~em cells 
towards the erythropoietic pathway and increase the nlUDber of erythro~ 
poietin·~sensitive precursors. This would propose a combined or conc•rte
activity ot two potent erythropoietic agenta, teato.'!terone and erythro-
poietin, acting at cU.tterent stages ot red cell tormat~on. 
In seemingly conflicting results, removal of endogenous testoster-
one by orchidectomy followed by lethal irradiation· and bone marrow re-· 
constitution haa been shown to increase the uptake ot 59Fe by the spleen 
(3). The role testosterone p1~• in erythrogeneaia is clearly a ~ery 
complex one and not well defined, but Morton (personal communication) 
has speculated that the sex hormones have· diftering ef tecta on marrow 
and splenic pluripotential stem cells. 
In 1970, Byron (54) studied the effect of single doses of various 
steroids on the cycling ot bone marrow stem cells. Using high specific 
activity 3H-thymidine lethal to replicating cells, he detefmined the 
per cent cell loss of femur marrow c.ells following steroid treatment. 
Cell loss was assayed by comparing spleen colony numbers in irradiated 
recipient mice. He found that the greatest sens~tivity to ~illing was 
in those cultures which had received testosterone propionate, etiocholan-
· l?pol-3-one, and to a lesser extent 19- norteatosterone phenylpropionate. 
Consequently, he proposed that these three steroids can ~rigg~r bon~ 
marrow cells from the resting G0 phase into the. s phase of DNA repli-
cation, an initial event in cellular division. 
13 
As previously mentioned, Fujii (37) was able to show a depletion 
ot the lymphocytic areas of thymus, spleen and lymph nodes, and a de-
crease in the numbers ot. antibody-producing cells to sheep erythrocytes 
in testosterone-treated, irradiated, and marrow reconstituted mice, 
effects not seen in irradiated, steroid untreated, controls. Further-
more, the most pronounced suppression of the plaque-forming eel~ re-
sponse produced by testosterone occurred when the regimen ot hormone 
injection followed a daily pattern up to seven days after irradiation 
(55). 
This period immediately following irradiation is the time in 
which a rapid regeneration of the cellular components.is taking place. 
They concluded that testosterone may act to alter the differentiation of 
stem cells at the expense of the lymphocytic series. Thus, histologi• 
cally, impaired lymphocytic regeneration would be expressed as deple-
tion of lymphocytes in those areas normally populated by this cell. 
A decrease in B-lymphocyte and plasma cell precursors could be manifest 
in a decrease in the plaque-form!ng cell response. 
In a study done by Porcellini (56), the in vivo effect Of teuto-
terone enanthate on bone marrow cells enclosed in intraperitoneally~ 
implanted diffusion chambers was ·followed. Fe~ale recipients previously 
received a single intramuscular injection of 2.5 milligrams testosterone 
enanthate in sesame oil. By day three following implantation of the 
chambers, an increase in the total cellularity and, differentially, an 
increase in granulocytes and macr.ophages waa observed as compared to 
implanted, stero;d-untreated, controls. 
14 
However, conflicting evidence has also appeared in the literature. 
Gonadectomized males, lethally irradiated and marrow reconstituted, ~ave 
been shown to afford an environment of enhanced spleen colony tonn~tion 
significantly higher than intact males and females,. (3). 
. . ' 
In an in vitro. study, Francis C.?7) showed that human peripher·a~. 
l;>lood leucocytea c~ be stimulated by teatoa~erone to ~•lease aoae .,:. 
factor into ·t~e me~ua. '!'hie conditioned aedium, when added tQ·cult~~· > 
ot bone marrow cells, stimulated an increaae in the ~umbe~a of aggregate 
cell colonies in the culture. 
The mechanism by which this hormone D1$.Y stimulate or modify the 
maturational direction of stea cell• has Deen the purpose of iuveati-
gations seeking a receptor tor teatoaterone in bone m~row c•lls. 
Minguell and Valladares (58) were unable to isolate a cytoplaamic 
receptor for testosterone in marrow cells. They did, however, confirm 
the existence ot a nuclear receptor. Minguell and Grant (59) then showed 
that testosterone itself and not 5«dihydrotestosterone ('°'DHT}, its 
major metabolite in androgen-dependent tissues, will stimulate·.· 
RNA synthesis as evidenced by incorporation of labelled formate ~nto 
RNA-adenine. This was confirmed by Byron (60) in a study of the Ttm 
mouse mutant. Thie mutant mouse strain lacks the receptor for 50CJ)HT. 
When multiple doses of this hormone were administered, incorporation 
ot 59Fe waa not stimulated, but the expected increase in committ.ed 
granulocyte· and macrophag~ precursors was not blocked. Therefore,· 
while erythropoietic stimulation seems to be mediated thrQugh the 
metabolite 5GCDHT 1 the selec~ive differentiation ot ~arrow. stem ce~ls to 
granulocyte/macrophage precursors is a result ot testosterone itself. 
I 
15 
In summary, evidence seems to indicate that testosterone may have 
its greatest etfect in modulating the differentiation ot bone marrow stem 
cells along the myeloid pathway with a competitive decrease in cells of 
the lympbocytic lineage. The mechanism involved may include a nuclear 
receptor tor testosterone which influences DNA and ~A synthesis. 
lbhanced red cell maturation seems to be mediated by the te•tosterone 
me~ab~lite, ,5ac.DHT. A serum factor liberated by steroid-activ~ted pe~i­
pheral leucocytes may also be involved in directing stem cell replica-
tion and differentiation along the myeloid pathway. 
The preaent study was designed to test the hypothesis that andro-
gen-induced immunosuppression is mediated by the prefe~ential differen-
tiation of stem cells along the myeloid pathway resulting in a loss of 
antibody-producing cells. 
CHAPTER III 
MA~ERIALS AND METHODS 
EXPERIMENTAL ANIMALS 
~~.anim~ls .used in thee~ experiments ••r• m•l• ~~!•male mice 
ot the Balb/c, DBJ\/2 an4 autoimmune NZB strains, and (}f~ X DBA/.2)F,-
&;n~ (Balb/c X DBA/2)F1 hybl_'ids. NZB breeders .were obtained in 196.6 
from Otago University Medical School, Dunedin, Ne~ Zealand where they 
were. in their fiftieth generation. Approximatel.y .15 generations have 
been bred in Dr. Siegel's laborato:ry since that time. DBA/2 and. Balb/c 
breeders were obtained from Jackson Laboratories in, Bar Har~9r, 
Maine. All mice were allowed to feed ad libitum on Purina Lab Chow 
-. 
except where x-irradiation had been used. ·in that case m~ce were fed. 
Purina Mouse Chow and drank water adjusted to pH 2.4 to minimize 
pseudomonaa infection. 
TESTOSTERONE ADMINISTRATION 
In initial experiments, testosterone propionate, ·250 micrograms, 
(United States Biochemical Corporation) was incorporated in 0.2 
milliliters corn oil and injected subeutaneoualy daily tor a peri_od of 
several weeks depending on the experiment·. Corn oil alone was used 
as a control. 
Later, testosterone propionate was delivered through ailastic 
implanfs (61,6~). These implants were prepared as follows: Medical 
... 
grade eilaatic tubing, outer diameter 0.125 centimeters (Dow Corning 
Corporation), was cut into two centimeter lengths. filled with 20 
milligrams testosterone propionate powder and then sealed with soft 
silicone rubber medical adhesive. Silicone Type A. Overnight air dry-
ing waa auttioient tor proper hardening ot the aott compound. 
CASTRATION AND IMPLANTATION 
17 
Castration waa performed through a scrotal incision. The teatea · 
were reaoved and blood vessels sealed with applied pressure. A stitch 
with 5-0 silk suture closed the wound. 
The ailastic tubes were implanted subcutaneously via a small in-
cision in the lower back. The incision was closed with one stitch of 
5-0 silk suture. In the initial experiments the implantation was de-
layed one week after castration. However, in later experiments both 
were performed on the same day. 
The anesthetic used tor all operations was ketamine hydrochloride 
(Briatol Laboratories). This was diluted 1:10 with o.85 per cent saline 
and given at a dose of approximately 0.25 cc per 20 grams body weight. 
The drug was administered intraperitoneally using a one milliliter 
syringe with a 25 gauge needle. After approximately 10 minutes, mice 
became limp and were taped with masking tape on an operating board 
tor surgical procedures. 
X-RAY TREATMENT 
One week prior to irradiation, all animals were switched from 
tap water to acid water, 0.006 molar HCl,.pH 2.4. Irradiations were 
18 
performed With an x-ray unit (PickerVanguard) operated at 277 kV peak 
and 15 MA with added filtration yielding a halt-value layer equivalent 
to 1.9 mmcu. The exposure rate averages 71 R per minute. Mice are ex• 
posed in plastic con~ainers mounted on a turntable which ~s rotated 
durlng exposure • 
. Immediately following irradiation each mouse was given a 0.1 cc 
subcutaneous injection ot the ~tibiotic Garamycin (Schering Pharma-
ceutical Corporation), at a dilution ot 1:10 in 0.85 per cent ~aline. 
The antibiotic was continued daily tor two weeks. At the end of the two 
week period, the animals were also taken off the acid water and re-
turned to tap water. 
IMMUNIZATION 
Antibody-producing capability was assayed following iJIJlunization 
with sheep erythrocytes. The erythrocytes, preserved in Alsevers' a.Q.ti-
coagulant, were obtained from Prepared Media Laboratory, Tigard, .Oregon. 
For each immunization an aliquot ot the cells was washed three times in 
phosphate buffered saline, pH 7.5, by centrifuging at 1600 rpm tor 10 
minutes. The buffered saline was then aspirated and the remaining cells 
·diluted 1:10 Wi.th o.85 per cent saline. Each mouse received 0.2 cc 
intraperitoneally. This has been calculated to represent a red cell 
8 dose of approximately 5 X 10 cells. The hemolytic plaque assay was 
performed o~ the fourth day following immunization on all strains ex-· 
cept the NZB and (NZB X DBA/2)F1 hybrid. Assay ot the NZB inice was per-
formed on day five sine~ this had been previ-Ously determined to be the 
day or peak antibody response. 
HEMOLYTIC PLAQUE ASSAY 
ibumeration Of antibody-producing cells Was determined by the 
hemolytic plaque assay of Cunningham and Sz~nberg (63). Mice were 
sacrificed by cervical dislocation, spleens removed and weighed,· ~d 
placed- on. ice. They. were t~en crµshe~ t.hrough ateri;l.• wire screens of 
. ~ ~ ~ 
0.2 millimeter mesh to ·obtain s·~nt;L• cell auep~n.e1ons. Phyaiosoi 
irrigation solution (Abbott LabQratories), pH 7.4~·was us•d t~ ·t1ush 
the screens and suspend the cells. The cella were .then centr1fuged 
19 
at 1?00 rpm for 20 minutes. The supernatant was remov~d-~y aspiration 
and the spleen ceil pellet resuspended in one or two milliliters of the 
physiosol irrigation solution depending on anticipate~ r·es;ponse·. · 
Clean and dry microcul ture plates were ua.ed to combine medium, com-
plement, antigen an~ spleen cells. To each well was added: 3 drops 
(each drop was standardized to appreximately 0.15 ml> of.lOX Me~ium 
199 diluted 1:10 with distilled water and adjusted to neutral pH with 
7.5 per cent sodium bicarbonate, one drop ot guinea pig serum (com-
plement) diluted 1:3 with diluted medium, one drop of washed s~eep 
erythrocytes diluted 1:5 in phosphate buffered aali~e, and 0.1 ml of 
the spleen cell suspension. Fach well ·was mixed and added to indiviual 
culture chambers. Chambers were prepared by pressing two microscope 
slides back to back With double~coated tape (Scotch Brand) affixed to 
the center and at each end. Thia created two chambers holqing a total 
volume of o.85 ml. After samples were introduced into the chamber. 
with a pasteur pipet, the edges were sealed by dipping in hot pa,ratfin. 
Fa.ch sample was then placed in a 37 degree centigrade.incubator for 30 
I 
I 
I 
I 
I 
• I 
20 
minutes. The plaques, consisting of round clear areas resulting from 
red cell lysis, were counted by hand lens magnification if the total 
number per slide yas between 50 and 200. If counts were greater than 
200 1 further dilutions of the spleen cell suspensions were prepared, the 
·samples replated and incubated, and the plaques recounted. Each sam-
ple at the tinal dilution was plated in triplicate, the average of the 
three counts used in computation of total plaque-forming cells per spleen 
and plaque-forming cells per milligram spleen weight. 
ORGAN WEIGHTS 
· In addition to the spleen, the thymus, both kidneys and semin~l 
vesicles .(uteri in females) were weighed on a Mettler Type H6 balance 
in order to assess the androgenic effects on these tissues. This 
assessment also served to confirm that the animal had absorbed the 
hormone from the implant since androgen is known to cause lymph~id 
tissue involution, and seminal vesicle and renal enlargement. 
BLOOD 
Blood samples were collected in heparinized microcapillary tubes 
(Scientific ·Products) by puncturing the retroorbital plexus. The samples 
were spun in an International microcapillary centrifuge tor three and 
one halt ~inutes and packed cell hematocrits read on an International 
microcapillary reader. .When appropriate, the plasma from these samples 
was colleot~d and assayed for antinuclear antibodies as described below. 
In some experiments, blood·was also obtained for hematological 
study. Total white cell numbers were counted using a hemocytometer 
21 
and slides stained with Gie~sa for differential readings. 
ANTINUCLEAR ANTIBODY ASSAY 
Antipuclear antibodies in the serum were detected by an inqir~ct 
.immunofluoresce~oe assay involving a tluorescein-conjugated goat anti-
mouse immunoglobulin ant~body tol~owing incubation ~f t,st mouse p~~s~a
samples with chicken erythrocyte nuclei as antigen. 
The chicken cell nuclei had been isolated as described by ~en Veen 
and Feltkamp (64) and were kept in the laboratory as a stock susp~nsion 
in 10 per cent neutral buffered formalin, pH 7.o. An aliquot ot ~his 
stock solution ot nuclei W&$ washed three times with pho~phate butt·ered 
saline and diluted 1:30 tor use. 
On a clean, dry microscope slide single drops of the nuclei were 
placed at tour sites along the length of the slide within approximately 
one centimeter of each other. The slides were then air dried for at 
least 45 minutes to fix the nuclei to the slide. 
Test mouse plasma samples were diluted 1:20 b1 adding five micro-
liters of plasma to 0.1 milliliters ot warm phosphate buffered ~al~ne 
(PBS). The chicken cell nuclei fixed to the slides were rehydrated.by 
placing the slide in warm PBS for 10 seconds. After wiping the slide 
dry around the nuclei, a drop of a diluted plasma sample was added to 
each area of nuclei by a nine inch pasteur pipet. The slides were then 
placed in closed plastic containers containing moistened paper towels 
and incubated at 37 degrees for 30 minutes. Fol.lowing incubation, the 
slides were placed in Wheaton jars with slide racks containing warm 
PB~ for five minutes. Three serial transfers to fresh PBS .. were made in 
22 
order to wash the slides. After wiping the slides dry around the test 
spots, one drop of fluorescein-conjugated anti-mouse immunoglobulin 
antibody, at a 1:30 dilution with PBS, was added to each sample. Slides 
were then incubated again for 30 minutes. The slides were washed three 
times again as previously described, followed by a final washing in 
distilled water. The slides ·were wiped dry around the spots and allow-
ed to completely air dry. Cover. slips were added over a thin layer of· 
buffered glycerol, pH 8.5. Slides were examined with a Leitz.flu9~e-
scent microscope. The light source was an HB200 (Osram1 Germany) high 
pressure mercury lamp and a primary B612 and an OGl bar~ier filter. · 
The intensity of fluorescence was rat~d on a o ~ 4+ scale with reactions 
of 2 o~ greater considered positive. 
STATISTICAL EVALUATION OF RESULTS . 
Most ot the data were evaluated using the student t test for 
significance. Statistic~lly significant results were those with p 
values less than 0.05. However, in cases where more than two groups 
-
were compared, analysis of variance was performed .followed· by Scheffe's 
teet tor significance. The p values are recorded in the bottom of 
the corresponding table. ~tatistically significant results were those 
with p values less than 0.05 •. 
CHAPTER IV 
RESULTS 
ORGAN WEIGHTS AND ANTIBODY PRODUCTION 
:· 
Tables I and II present the effects on selected organ weights 
and antibody formation in the male DBA/2 and NZB mouse strains seven 
weeks following sham or testosterone implantation and castration. 
As might be expected, the organ most dependent on testosterone for 
its integrity is the seminal vesicle. Castration plus the sham implant 
resulted in a marked decrease in the weight of this organ. Tho$e cas-
trated mice that had received the testosterone implant showed a slight 
increase in seminal vesicle weight but was not significant compared to 
normal, intact mice. 
Kidney weights also responded to treatment in both strains. 
The combined weight of both kidneys decreased with castration_and in-
creased With the te$tosterone implant. The thymus responded to treat-
ment as anticipate~; hypertrophy resulted from castration alone, while 
marked involution occurred with testosterone treatment. While castra-
tion alone produced a significant increase in spleen weight compared to 
both.intact and testosterone-treated groups ot the DBA/2 strain, testo-
sterone administration had no significant effect compared to intact males. 
However, manipulation of testosterone levels had no significant effect 
on spleen weights of the NZB strain. DBA/2 mice did not show any 
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significant differences in the numbers of antibody-producing cells per 
spleen or per milligram spleen as determined by the hemolytic plaque 
assay folloWing either castration or castration plus testosterone 
supplementation. The castrated, testosterone-treated NZ~ ~1~· did, 
however,. show a significant suppression of an'l;ibody response per< ·~Pl~en 
compared to intact controls. 
A group of intact NZB temales which had been injected ~~ly wit4 
testosterone dissolved in corn oil or corn oil alone as controls·tor 10 
weeks displayed marked differences in all parameter• (Table III). ·The· 
kidneys increased in size with testosterone treatment as, remarkably, 
did the uteri'. .Although thymic involution, as in the males, was eviden~ . 
with testosterone treatment of females, the female spleen weights also 
decreased With hormone treatment, an· effect not.observed in the castrated, 
testosterone-treated males. The spleens of these animals also showed.a 
small, but significant, decrease in antibody response comp.red to females 
receiving corn oil injections alone. 
Because the mice in these experiments did.not show striking diff- · 
erences in spleen weights or antibody formation, it was decided to 
evaluate these parameters in treated mice undergoing hemopoietic.regen-
eration following subletha.1 irradiation. Table IV compiles the results 
of such an experiment using NZB females, sham or testosterone implanted, 
followed three weeks later by exposure to 550 rads of whole body 
x-irradiation. These data were collected six weeks -~ft.er irrad1at1.on. 
. . 
Kidney weights were increased with testosterone treatment, while thymic 
weights were markedly decreased. No significant differences in uterine 
or splenic weights were observed. However, both ·the numbers of p~aque-
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forming cells per spleen and per milligram spleen were significantly 
suppressed in the testosterone-treated groups, by as much as four-fold. 
Balb/c males and females were also examined using the experimental 
system involving hormone treatment and irradiation. Lymphoid organ 
weights and antibody formation in Balb/c males were examined five 
{Table V) and nine (Table VI} weeks following irradiation. At five 
weeks, the thymus weight changes followed the same pattern previously 
described for the mice in Tables I-IV; testosterone produced thymic in-
volution 1 while castration resulted in hypertrophy. While there was 
no difference in splenic weights between the intact group and the 
castrated plus testosterone-treated group, the castrated, sham-treated 
maleQ showed a significant increase in splenic weight compared to both. 
The number of plaques per spleen from the castrated, sham-treated males 
were significantly higher from both the intact and castrated plus testo-
sterone groups. There was no difference between intact and testosterone-
treated males. After adjusting for differences in spleen weight, the 
PFC•s'per milligram spleen were not significantly different between 
any of the three groups. At nine weeks, Table VI, the organ weights 
and antibody responses exhibited the same patterns evident at five 
weeks. Antibody responses per spleen were greatest in the castrated, 
sham-implanted males, while no significant difference was observed 
between intact and castrated, testosterone-treated mice. However, the 
number of PFC•s per milli~ram spleen were significantly different when 
comparing castrated, sham- and testosterone-treated groups. 
Balb/c females, either sham- or testosterone-implanted one day 
bef9re radiation exposure, also showed significant differences in organ 
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weights and antibody response (Table VII). At both five and eight weeks 
folloWing irradiation, thymic and splenic weights were decreased with 
testosterone treatment. Significant suppression ot PFC•s per spleen 
was produced by the hormone at both five and eight weeks, however, the 
differences in PFC•s per milligram spleen were not statistically signi-
ficant. 
In yet another experiment using (Balb/c X DBA/2)F1 hybrid males 
and females, similar ~esponaes were observed (Tables VIII and IX). For 
the males (Table VIII), 10 weeks after irradiation, organ weights were 
modified as previously described for Balb/c strain mice (Tables V and 
VI). Here, numbers of PFC•s per milligram spleen were significantly 
different in all experimental groups. Testosterone produced marked 
suppression of responses to sheep erythrocyte immunization, while cas-
trated, sham-implanted males exhibited the greatest number of antibody-· 
producing cells per milligram spleen. 
Table IX demonstrates t~at numbers of PFC•s per milligram spleen 
in the (Balb/c X DBA/2)F1 females at both eight and 12 weeks after 
irradiation are significantly suppressed by testosterone treatment. 
Recovery from irradiation has continued to progress between eight and 
12 weeks as evidenced by the increase in numbers of PFC•s of both groups 
with time. 
HEMATOLOGY 
Total peripheral white cell counts and differentiation ot blood 
leucocytes were also performed on castrated and testosterone-treated 
groups in order to determine whether changes occurred that could be 
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correlated with observed changes in lymphoid organ we~ghts and immune 
capacity. Initial studies using castrated male mice compared to inta~t 
controls demonstrated that castration can modify blood cell counts. 
Table X shows the lymphocyte and polymorphonuclear leucocyte (PMN)· 
counts of castrated three month old DBA/2 and NZB males castrated at 
two montha ot ag' compared to their .intact litter mates. Lymphocyte· 
counte of both intact and caetrated-DBA/2 males were comparable• HoW~ 
ever, castration produced a significant decrease in the numbers ot PMN•e •. 
Interestingly, in the NZB strain a small, but significant, increase in 
the lymphocyte count followed castration, whereas no d~fference was 
observed in the numbers of PMN•a between the two groups. An observable 
decrea•e in the red cell population following castration was also noted 
in th~ NZB strain, but not detectable in the DBA/2 1 With average hema-
tocrit values of 44 per cent for the castrated and 4? per cent for the 
normal mice. No differences in numbers of total white cell counts, 
monocytes, or eosinophils were observed in either strain. 
Figure 2 compares.the lymphocyte and PMN numbers of the hormone-
treated and irradiated Balb/c males and females whose lymphoid organ 
weights and PFC responses were previously described in Tables V-VII. 
All mice received 400 rads of whole-body x-irradiation. At seven weeks 
following irradiation, the male intact control group shows an approxi-
mate PMN:lymphocyte rat~o of 3.5:4.5. The castrated, sham-implanted 
males exhibited a significant elevation in lymphocyte count, but no 
evident difference in the absolute number ot PMN•s compared to the 
~ irradiated controls. This suggests that physiological levels of testo-
sterone in the male delays the post-irradiation recovery of the lympho-
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cyte population. Testosterone treatment, with pharmacological doses, 
following castration resulted in a reversal of the PMN:lymphocyte ratio 
(3:1) seven weeks after radiation exposure. The PMN•s were significantly 
higher than for both the castrated, sham-implanted males and control 
groups, and the lymphocyte count was significantly decreased. Sham-
implanted1 age-matched, females seven weeks after irradiation produced 
a PMN:lymphocyte ratio of approximately 1:2, values closely resembling 
those of the castrated males. Here again, testostero~e treatment ot 
intact females resulted in a reversal of the granulocyte:lymphocyte 
ratio (2:1). This was almost entirely due to a lymphocytopenia since 
a PMN elevation similar to that seen in the testosterone-tre~ted male 
castrate was not observed here. No significant differences in hema-
tocri t values averaging about 46 per cent, total white counts, monocytes, 
or eosinophils were observed between any of the male or female groups. 
Figure 3 shows PMN and lymphocyte numbers obtained eight and 
12 weeks folloWing 500 rads of irradiation and testosterone treatment 
tor the (Balb/c X DBA/2)F1 hybrid females whose organ weights and 
plaque values were previously descriQed in Table IX. TestQaterone 
treatment resulted in a delay in lymphocyte recovery at eight weeks 
after irradiation with a concurrent increase in PMN•s. By 12 weeks, 
this effect was no longer evident an~.no statistical differences were 
observed between the sham- and testosterone-treated groups suggesting 
that the effect on the peripheral blood picture of a single implant 
of testosterone had worn Off. It should be recalled (Table IX) that 
at 12 weeks poet-irradiation, immunosuppression was still evident in 
.the testosterone-treated group. 
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Otherwise untreated male and female (Balb/c X DB.A/2)F1 hybrids 
also showed innate sex differences in hematological recovery tolloWing 
400 rads ot x-irradiation (Figures 4 and 5). Normal PMN and lymphocyte 
numbers of untreated mice ot both sexes were approximately 3000 and 
9000 cells per cubic millimeter, respectively. At four weeks after 
irradiation, lymphocyte counts tor both males and females were approxi-
mately. 3000 cells per cubic millimeter. By nine weeks, lymphocyte 
numbers were further approaching normal and no significant differences 
between the males and females was observed. Although unirrad.iated 
normal males and females do show slight, but insignificant, dif~erenc·es 
in numbers of PMN• s, there were significant differences in these ce.ll 
numbers during recovery. Males consistently showed significantly 
higher numbers of PMN•s at four, nine and 18 weeks.post-irradiation. 
ANTINUCLEAR ANTIBODY FORMATION· 
Previous work in this laboratory has not shown any sex differences 
in the development or levels of antinuclear antibodies (ANA) in the 
NZB strain. Furthermore, results of ANA assays performed over a per-
iod ot time revealed no differences between castrated and control 
groups ot male NZB mice. Orchidectomy had been performed on these 
mice at· three months ot age. Autoantibody levels rose evenly in both 
groups as the animals aged. Orchidectomy was not oba~rved to preci-
pitate ANA formation in non-autoimmune strain mice either. For 
example, no ~A. was detected in (Balb/c X DBA/2)F1 mice castrated at 
two months of age and assayed periodically over the next nine months. 
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NZB females receiving injections of testosterone dissolved in corn 
o~l or corn oil alone were also assayed perio~eall~ for ANA. Exogenous 
testosterone had no effect on ANA titers, which increased with (lie in 
a simila~ manner. in both groups. 
Comparable results were observed in irradiated, testosterone-
and sham-treated NZB males. Here, testosterone tr•atment afforded no 
apparent protecti~n against the development ~t antinuclear antibodies 
during recovery from x-irradiation. 
i 
I 
• t 
CHAPTER V 
DISCUSSION 
ORGAN WEIGHT CHANG&S 
 
The seminal vesicles are, of course, dependent on androgen for 
their growth and maintenance throughout life. In all of these experi-
ments, the size of the seminal vesicles was reduced to only a few 
milligrams after removal of androgen by orchidectomy; Testosterone 
supplementation acted to increase their size over that in. intact con-
trols. In the female mice, the uteri in many cases also increased ,in 
weight with testosterone supplement. Giannopoulous (65) has shown 
that there are testosterone-specific receptors in x·at uteri which 
may mediate this effect. 
The kidneys are also a target organ tor testosterone as reflected 
in the fluctuations in· weight observed here upon hormone treatment. 
Testosterone eupplements were capable of stimulating large increases 
in size and weight. And, since castration resulted in·significant 
decreases in kidney weights, androgen would appear to play a role, not 
only in stimulation of growth, but also in the continued maintenance 
of normal kidney size and weight. In this regard, normal NZB female 
kidneys were significantly smaller (p<.025) than kidneys of NZB males. 
But, receptors for testosterone also appear to be present in female 
kidneys (66), since kidney weights increased in females treated with 
testosterone. This may, in part, be due to the androgen-induced pro-
duction ot elevated levels of erythropoietin by the kidneys (51,52). 
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It has been known for several decades that steroid treatment will 
produce thymic invo~ution (13,14,15). Our experimental data are in 
agreement With these early investigations. !n. vitro studies had sug-
gested lymphocytolysis as a mechanism of initial thymic degeneration 
(241 25,26). However, our hematological data showed no increase.in 
peripheral smudge o~ degenerative cells in testosterone-treated mice. 
A viable explanation tor this finding c.ould be that our earliest time 
point tor the collection of hematological data was not soon enough after 
hormone administration. Degenerative changes in thymic structure have 
been detected as e.arly as six hours following a single injection ot 
ACTH (22,23). Sustained thymic atrophy could be related to the observed 
decreases in peripheral lymphcyte numbers with testosterone treatment. 
The Balb/c males and females described in Tables V and VII exhibited 
significant differences in thymic weight recovery five weeks tolloWing 
irradiation. The lymphocyte recovery at seven weeks after irradiation 
paralleled the pattern of thymic weight recovery. In testosterone-
treated ~ale and female mice, both the thymic weights and lyraphocyte 
counts were decreased, while in castrated, sham-treated males, both 
parameters increased. This parallel·~etween thymic· density and peri-
pheral lymphocyte numbers~ during recovery from irradiation' ia to be·· 
~nticipated 1 since T. cells undergo their i~itial maturation in' the 
thymus and then seed the periphery. Furthermore, Fujii (37) bas shown 
that irradiation and a single 10 milligram injection of testosterone 
severely depletes T-independent regions of spleen, lymph nodes and 
': 
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Payers' patches. A parallel between B-cell regeneration and peripheral 
blood lymphocyte restoration would require examination of recovery 
patterns of cellularity of T-cell independent areas of the spleen and 
lymph nodes tallowing irradiation. Quantitation of peripheral lympho-
cytes tor relative numbers of T- and B-cella by assessment of the pre~ 
sence ot theta antigen and immunoglobulin, respectively, would also 
clarity the question ot relative rate~ ot restoration of the· different 
lymphocyte s~bpopula~ions and their sensitivity to testosterone. Th•se 
are subjects tor tuture investigation. 
Thymus weight also appeared to vary with time ~fter irradia~ion. 
The relative size of thymuses at eight and nine weeks af~er irradia-
tion Of.the females and males, respectively, were smaller cpmpared to 
corresponding groups at the five week interval (Table' ·v-VII). The 
larger weights observed at five weeks may be the result of an over-
shoot phenomenon associated with the initial regenerat1·ve burst ot the. 
marrow following irradiation. By eight .or nine weeks. the rate of :pro~ 
liferation,ot the marrow. and he.nee the number of thymus-bound lympho-
cytes may have returned more to normal and thymus we;g~ts are decreased 
as mature thymocytes leave the organ. 
Spleen weights were observed to be· tar more variable. Cas.trati,on 
resulted in a consistent augmentation of spleen weight r'ecovery follow-
ing irradiation. But testosterone supplementation was, in.many cases, 
unable to produce a corresponding decrease. A likely explanat~on may 
involve the complicating factor ot erythropoiesis. The spleen is a site 
ot active red cell formation i~ the mouse as well-as b~ing rich in 
immunocytes. As testosterone has also been shown to have ~otent 
·erythrogenic properties, any loss of splenic weight due to decreased 
lymphocyte numbers may net always be visible because of activated red 
blood cell ~ormation. 
ANTIBODY FORMATION AND RELATION TO ST.EM CELL DIFFERENTIATION 
Most importantly, this study has demonetrated that testoste~one 
Q8:U markedly suppress antibody formation un~er certain. condition~. Wbeh 
testosterone was adm.ini•tered by silastic implants over a period of 
seven weeks to castrated DBA/2 and NZB males that had not been irradiated, 
it had a minimal effect on the numbers of plaque-forming cells in the . 
spleen {Tables I and II). However, NZB females receivi~g daily injec~ 
tions ot 250 micrograms of testosterone in corn oil for 10 weeks, sh~wed · 
a marked suppression of PFC response (Table III).. Those differences may 
be due, in part, to length of time of testosterone treatment. The 
failure of teatosteron~ and castration to produ~e marke~ changes in 
the male NZB and DBA/2 may have been related to mouse strain differences 
in responsiveness to these manipulations. Cohn and Hamilton did demon-
strate strain difter·encea in sensitivity to androgen (67). 
In contrast, all the mice studied here, male or female, that re-
ceived sublethal irradiation subsequent to hormone treatment were immuno-
suppressed. These results suggested that the immunosuppressive effects 
Of· testosterone may be mediated primarily by the bone marrow stem cell 
and its differentiation. These events are magnified during recovery 
trom irradiation and have thus provided .a very sensitive experimental 
system for discerning the influence ot testosterone on the immune system. 
Hematological studies during radiation r~covery showed that testoste-rone 
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can modify the peripheral lymphocyte population and result in decreased 
numbers ot lymphocytes. Radiation treatment is primarily cytotoxic to 
stem cells of the bone marrow, but is also believed to cause selective 
depletion of B-cell dependent ~reas of spleen and lymph nodes. Mature 
thymocytes and neutrophils are relatively radioresistant {68). ~~ . 
effect of irradiation is, the~efore, to produce a rapidly regenerating .. 
hemopoietic system. The hematology .Picture follofling irradiation wou~d 
suggea~ that testosterone.may be acting at the level ot stem cell or 
committed progenitor cell. Byron (54) had shown that testosterone· can 
initiate bone marrow stem cells into cycle.· It has also been observed 
boUnd to a nuclear receptor in the nucleus of stem cells {58) •. It may 
be selectively stimulating the generation of erythrocytes and -granulo-
cytes, particularly neutrophils, at the expense of the lymphooytic 
series. This would in~icate an hormona~ modulation of stem cell diff-
erentiation and produce competition between the myelopoietic an4 lymphoid 
pathways. This mechanism could explain the increase in PMN's and the 
concurrent decrease in lymphocyte numbers following testosterone and 
radiation treatme.nt. The selective loss of B-cells_ upon irradiation, 
comb~ned with a diminished eapaci ty tor their regeneration. p:fo/iuced by 
testos~erone treatment could conceivably account for the suppressed 
antibody reaponse. Without irradiation to produce an initial depletion 
ot cells and stimulate rapid regeneration, testosterone may only act . 
on the relatively slow, natural process of continual regeneration occurr-
ing in the adult animal. This may account for the lack of an observable 
effect of seven weeks of hormone treatment on th9 PFC response of the 
unirradiated DBA/2 and NZB mice. However, the NZB females that received 
I 
. I 
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·testosterone over a period of 10 weeks did show ·differences in antibody 
formation. Time could be an important factor in this case. 
Even after the peripheral blood picture (Figure 3) and spleen and 
thymus weights (T~ble IX) had returned to normal, female (Balb/c X DB.A/2) 
mice that had been irradiated and testosterone-treated 12 weeks earlier 
rema:ined significantly immunosuppressed. This has suggested a pos~ibl~ 
·selective $ensitivity of some immunoreactive cell type to the intiuence 
ot testosterone, particularly during its ditterentiation and ma~uration. 
ANTINUCLEAR ANTIBODY FORMATION 
No protective effects of testosterone on ANA titers in the auto-
immune-prone NZB strain were observed, either in intact mice or in sub-
lethally irradiated animals. It is interesting to note.that plasm~ cQlls· 
are thought to be radioresistant (68). It seems possible that although 
radiation and testosterone treatment have marked immunoauppressive 
effects on antibody formation to newly introduced antigens, previously 
activ~ plasma cells would be unaffected by the treatment. However, 
an early post-irradiation drop in ANA titers followed by rapid recovery 
has been noted. This has suggested that the ANA-forming cell haa a 
rapid. turn-over rate. which may not be testosterone sensitive. 
CHAPTER VI 
CONCLUSIONS 
Immunological tissues are receptive to androgenic intlue~ce 1 . 
since testosterone produces marked change~ in the lymphoid cellularity 
ot the thymus 'A!ld the peripheral blood, and, tQ a lesser extent, ·the 
spleen. Removal of hormone by castration produced an environment 
capable ot enhancing lymphoid organ growth and cell production. 
At the doses and under the amplifying conditions of sublethal 
irradiation, used in these experiments, testosterone could p~oduce 
severe depression of antibody formation to sheep erythrocytes in ~he 
spleen. It also appears to selectively stimulate myeloid regenera-
tion in. irradiated mice at the expense ot lymphocytopo~esis. It.is 
not yet clear whether there is an inhibitory effect of .testosterone 
on the differentiation and maturation of one or more lymphocyte sub-
populations, or wheth~r the effect is a passive diversion of a limited 
number of hemopoietio stem cells along myeloid pathways of differentia-
tion. 
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